2023-08-14T13:57:18-05:00 2022-12-31 812950760 SAX LLP 1040 AVENUE OF THE AMERICAS-16TH FL NEW YORK NY 10018 990 2022-01-01 133174839 THE GLAUCOMA FOUNDATION INC GLAU 2126511900 80 MAIDEN LANE 700 NEW YORK NY 10038 ELENA STURMAN PRESIDENT & CEO 2126511900 2023-08-14 1 ELENA STURMAN 999009999 0 MIKE SCHALL P02024184 2126618640 2023-08-11 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z ELENA STURMAN 80 MAIDEN LANE 700 NEW YORK NY 10038 2938589 0 X GLAUCOMAFOUNDATION.ORG X 1984 NY TGF IS AN INTERNATIONAL NOT-FOR-PROFIT ORGANIZATION DEDICATED TO ERADICATING GLAUCOMA. 22 22 5 0 0 0 3616583 2557425 0 0 620531 325797 60000 30000 4297114 2913222 784037 445000 0 0 898830 938742 30000 30000 323115 817592 770999 2530459 2184741 1766655 728481 12951160 12309626 598480 554217 12352680 11755409 X THE GLAUCOMA FOUNDATION IS AN INTERNATIONAL NOT-FOR-PROFIT ORGANIZATION DEDICATED TO ERADICATING GLAUCOMA, THE LEADING CAUSE OF PREVENTABLE BLINDNESS. THE STRATEGY TO ACHIEVE THIS GOAL IS TWO-FOLD: RAISE PUBLIC AWARENESS CONCERNING THE NECESSITY OF ROUTINE EYE EXAMS, AND FUND CRITICAL RESEARCH TO FIND CURES FOR GLAUCOMA. 0 0 1591392 445000 MEDICAL RESEARCH: THE GLAUCOMA FOUNDATION AWARDS GRANTS-IN-AID FOR GLAUCOMA RESEARCH IN THE FOLLOWING DISCIPLINES:1. OPTIC NERVE RESCUE AND RESTORATIONS- NEUROPROTECTANTS AND THEIR ROLE IN GLAUCOMA- REVERSAL OF DYSFUNCTION OF DAMAGED RETINAL GANGLION CELLS- RETINAL GANGLION CELL AXONAL REGENERATION- OPTIC NERVE TRANSPLANTATION2. MOLECULAR GENETICS- RESEARCH INTO THE GENETIC CAUSES OF THE VARIOUS FORMS OF GLAUCOMA, PARTICULARLY THE IDENTIFICATION OF THE RESPONSIBLE GENES, WITH THE LONG-TERM GOAL OF FINDING WAYS TO REVERSE THESE GENETIC DEFECTS.3. NANOTECHNOLOGY- RESEARCH INTO THE USE OF NANOTECHNOLOGY FOR MONITORING IOP, DIAGNOSING AND MONITORING DAMAGE TO THE OPTIC NERVE AND DELIVERING DRUGS AND OTHER THERAPIES.GRANTS ARE AWARDED FOR A ONE-YEAR PERIOD AND ARE RENEWABLE. THE MAXIMUM AMOUNT OF FUNDS AWARDED FOR A ONE-YEAR PERIOD IS $60,000 PER GRANTEE. RESEARCHERS MAY ALSO APPLY FOR A ONE-TIME EXPANDED GRANT RENEWAL UP TO $60,000 FOR A SECOND YEAR. FUNDS ARE NOT TO BE USED FOR SALARIES, PERSONNEL SUPPORT, OVERHEAD OR OTHER INDIRECT COSTS. ALL REQUESTS FOR GRANTS MUST BE MADE IN WRITING ON THE FOUNDATION'S APPLICATION FORM AND SUPPORTING DOCUMENTATION MUST INCLUDE A DESCRIPTION OF THE OBJECTIVES, BACKGROUND, METHODOLOGY, SIGNIFICANCE, ANY PRELIMINARY RESULTS, AND BUDGET FOR THE PROJECT.THE FOUNDATION ALSO SPONSORS THE ANNUAL SCIENTIFIC THINK TANK ON OPTIC NERVE RESCUE AND RESTORATION, A WORLDWIDE COLLABORATION OF LEADING SCIENTISTS AND RESEARCHERS POOLING THEIR EFFORTS TO SEEK A WAY TO REVERSE OPTIC NERVE DAMAGE.PUBLIC EDUCATION: THE GLAUCOMA FOUNDATION DISTRIBUTES THE FOLLOWING PUBLICATION ON REQUEST TO THE GENERAL PUBLIC AT NO CHARGE:- A 20-PAGE COLOR BROCHURE, DOCTOR, I HAVE A QUESTION, A GUIDE FOR PATIENTS AND THEIR FAMILIES- A QUARTERLY NEWSLETTER, EYE TO EYE- A LEAFLET, GLAUCOMA: THE LEADING CAUSE OF PREVENTABLE BLINDNESS, A BRIEF GUIDE DESCRIBING GLAUCOMA AND TREATMENT FOR GLAUCOMA. 1591392 1 1 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 0 1 1 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 1 5 1 0 0 0 0 0 0 0 0 0 0 0 0 X 22 22 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 NY AL AK AR CA CO CT FL GA HI IL KS KY ME MD MA MI MN MS NH NJ NM NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X ELENA STURMAN 2122850080 80 MAIDEN LANE SUITE 700 NEW YORK NY 10038 GREGORY K HARMON CHAIRMAN 1.00 X X 0 0 0 ROBERT RITCH FOUNDER 1.00 X X 0 0 0 BALDO SCASSELLATI SFORZOLINI DIRECTOR 1.00 X 0 0 0 SALVATORE CIAMPO DIRECTOR 1.00 X 0 0 0 REZA DIBADJ DIRECTOR 1.00 X 0 0 0 MURRAY FINGERET DIRECTOR 1.00 X 0 0 0 DAVID FELLOWS DIRECTOR 1.00 X 0 0 0 PAUL L KAUFMAN DIRECTOR (THRU 6/30/22) 1.00 X 0 0 0 BARRY S FRIEDBERG DIRECTOR 1.00 X 0 0 0 JEFFREY M LIEBMANN DIRECTOR 1.00 X 0 0 0 KUMAR MAHADEVA DIRECTOR 1.00 X 0 0 0 KENNETH MORTENSON DIRECTOR 1.00 X 0 0 0 NAJ SHARIF DIRECTOR 1.00 X 0 0 0 JAI G PAREKH DIRECTOR 1.00 X 0 0 0 PATRICIA HILL DIRECTOR 1.00 X 0 0 0 JOE ROSEN DIRECTOR 1.00 X 0 0 0 LOUIS PASQUALE DIRECTOR 1.00 X 0 0 0 SHELDON M SIEGEL DIRECTOR 1.00 X 0 0 0 BARBARA CALABA DIRECTOR 1.00 X 0 0 0 CAROLE DARDEN-LLOYD DIRECTOR 1.00 X 0 0 0 ALON HARRIS DIRECTOR 1.00 X 0 0 0 ANNETTE GROLLMAN DIRECTOR 1.00 X 0 0 0 BARBARA HEARST DIRECTOR 1.00 X 0 0 0 NILDA RICHARDS CONTROLLER & TREASURER 40.00 X 98171 0 21941 ELENA STURMAN PRESIDENT & CEO 40.00 X 376001 0 30768 CLY FOWKES DIRECTOR OF SPECIAL PROJECTS 40.00 X 131902 0 23184 606074 0 75893 2 0 1 0 0 2557425 2557425 135466 135466 215698 25367 190331 190331 190331 OTHER INCOME 900099 30000 30000 30000 2913222 30000 0 325797 385000 385000 60000 60000 526882 368817 56374 101691 301817 254423 22335 25059 9032 7610 664 758 54687 43467 1806 9414 46324 35003 4214 7107 30000 30000 122006 122006 64659 30000 34659 36674 27711 3335 5628 97822 73915 8897 15010 12725 12725 2720 2055 247 418 6854 5179 623 1052 DIRECT MAIL 213760 106880 106880 COMMUNITY OUTREACH 146688 146688 OTHER 40324 7410 12816 20098 POSTAGE AND SHIPPING 26767 24509 2258 2184741 1591392 270234 323115 1144101 831853 2455337 2611637 335782 25000 14101 48048 97438 93465 5767 3973 8968276 8583863 27796 205252 12951160 12309626 47222 50382 543187 315000 8071 188835 598480 554217 X 6430846 7033197 5921834 4722212 12352680 11755409 12951160 12309626 728481 -1325752 0 X 0 1 X 1 0 X 1036677 2083603 2283227 3616583 2557425 11577515 1036677 2083603 2283227 3616583 2557425 11577515 3691739 7885776 106888 124172 107891 98435 325797 763183 60000 30000 90000 12430698 0.63440 0.62170 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 9907875 213554 -1150556 213376 8757497 8269730 928876 1587431 878162 9907875 7068382 796746 955139 550537 8269730 5870246 483214 1221076 506154 7068382 6530767 162550 -670571 152500 5870246 0.46840 0.53160 0 0 97438 93465 3973 3973 OPERATING LEASE LIABILITY 188835 188835 X 1465464 -1325752 -1325752 2791216 122006 122006 2913222 2062735 0 2062735 122006 122006 2184741 PART V, LINE 4: THE ORGANIZATION'S ENDOWMENT FUNDS ARE INTENDED TO BE USED FOR MEDICAL RESEARCH GRANTS. PART X, LINE 2: THE FOUNDATION DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE ANY MATERIAL, UNCERTAIN TAX POSITIONS. TAX FILINGS FOR PERIODS ENDING DECEMBER 31, 2019 AND LATER ARE SUBJECT TO EXAMINATION BY APPLICABLE TAXING AUTHORITIES. 1 NORTH AMERICA GRANTS GRANTS 60000 0 0 0 0 0 0 60000 0 60000 NORTH AMERICA MEDICAL RESEARCH 60000 CHECK 0 0 0 0 0 0 0 PART I, LINE 2: RECIPIENTS MUST SUBMIT SEMI-ANNUAL REPORTS SHOWING PROGRESS AND EXPENDITURES. PART III ACCOUNTING METHOD: X X X 1 FAIRCOM NEW YORK 12 WEST 27TH ST FLOOR 13 NEW YORK NY 10001 DIRECT MAIL & FUNDRAISING 0 458591 60000 398591 458591 60000 398591 1 RESEARCH TO PREVENT BLINDNESS 360 LEXINGTON AVE FL 22 NEW YORK NY 10017 131945117 501(C)(3) 75000 0 MEDICAL RESEARCH REGENTS OF THE UNIVERSITY OF MICHIGAN 500 S STATE STREET ANN ARBOR MI 48109 386006309 501(C)(3) 60000 0 MEDICAL RESEARCH TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 622 WEST 113TH STREET 4524 NEW YORK NY 10025 135598093 501(C)(3) 250000 0 MEDICAL RESEARCH PART I, LINE 2: RECIPIENTS MUST SUBMIT SEMI-ANNUAL REPORTS SHOWING PROGRESS AND EXPENDITURES. X X X 0 0 0 0 0 0 0 0 0 ELENA STURMAN PRESIDENT & CEO 376001 0 0 0 0 0 11180 0 19588 0 406769 0 0 0 CLY FOWKES DIRECTOR OF SPECIAL PROJECTS 131902 0 0 0 0 0 3957 0 19227 0 155086 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B LINE 11B EXPLANATION - THE CHIEF EXECUTIVE OFFICER AND THE ASSISTANT TREASURER REVIEW THE FORM 990 IN DETAIL AND THEN MAKE IT AVAILABLE TO THE GOVERNING BOARD PRIOR TO BEING FILED. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION HAS A BOARD APPROVED CONFLICTS OF INTEREST POLICY. EACH BOARD MEMBER MUST FILL OUT AN ANNUAL DECLARATION STATING THEY HAD NO CONFLICTS OR IDENTIFYING THE NATURE OF THEIR INTERESTED PARTY TRANSACTIONS. FORM 990, PART VI, SECTION B, LINE 15A EACH YEAR, THE EXECUTIVE COMMITTEE REVIEWS COMPARABLE SALARIES BASED ON A RECOGNIZED STUDY AND REVIEWS THE PERFORMANCE OF THE EXECUTIVE DIRECTOR TO DETERMINE IF THE EXISTING SALARY FALLS WITHIN THESE RANGES. AFTER A DELIBERATION OF THIS MATTER, A NEW PROPOSED SALARY AND BENEFIT PACKAGE IS VOTED ON. THE MINUTES OF THE BOARD OF DIRECTORS REFLECT THE NATURE OF THIS PROCESS EACH YEAR, THE EXECUTIVE COMMITTEE REVIEWS COMPARABLE SALARIES BASED ON A RECOGNIZED STUDY AND REVIEWS THE PERFORMANCE OF THE PRESIDENT/CEO TO DETERMINE IF THE EXISTING SALARY FALLS WITHIN THESE RANGES. AFTER A DELIBERATION OF THIS MATTER, A NEW PROPOSED SALARY AND BENEFIT PACKAGE IS VOTED ON. THE MINUTES OF THE BOARD OF DIRECTORS REFLECT THE NATURE OF THIS PROCESS FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS PUBLIC DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO PUBLIC.